BLUEJETPharmaceuticals
Blue Jet Healthcare Ltd — Profit & Loss Statement
₹327.25
-2.72%
Blue Jet Healthcare Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| EBIT | 406.20 Cr | 220.26 Cr | 217.97 Cr | 246.51 Cr | — |
| Net Interest Income | -0.10 Cr | -0.16 Cr | -0.77 Cr | -2.86 Cr | — |
| Interest Expense | 0.10 Cr | 0.16 Cr | 1.36 Cr | 3.28 Cr | — |
| Normalized Income | 305.20 Cr | 171.00 Cr | 154.67 Cr | 180.41 Cr | — |
| Net Income From Continuing And Discontinued Operation | 305.20 Cr | 163.75 Cr | 160.03 Cr | 181.59 Cr | — |
| Total Expenses | 670.04 Cr | 510.46 Cr | 526.52 Cr | 450.98 Cr | — |
| Diluted Average Shares | 17.35 Cr | 17.35 Cr | 17.35 Cr | 17.35 Cr | — |
| Basic Average Shares | 17.35 Cr | 17.35 Cr | 17.35 Cr | 17.35 Cr | — |
| Diluted EPS | 17.59 | 9.44 | 9.23 | 10.47 | — |
| Basic EPS | 17.59 | 9.44 | 9.23 | 10.47 | — |
| Diluted NI Availto Com Stockholders | 305.20 Cr | 163.75 Cr | 160.03 Cr | 181.59 Cr | — |
| Net Income Common Stockholders | 305.20 Cr | 163.75 Cr | 160.03 Cr | 181.59 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 305.20 Cr | 163.75 Cr | 160.03 Cr | 181.59 Cr | — |
| Tax Provision | 100.90 Cr | 56.34 Cr | 56.58 Cr | 61.64 Cr | — |
| Pretax Income | 406.10 Cr | 220.09 Cr | 216.61 Cr | 243.23 Cr | — |
| Other Non Operating Income Expenses | 46.26 Cr | 28.86 Cr | 1.39 Cr | 0.26 Cr | — |
| Special Income Charges | 0.00 | -9.74 Cr | 0.10 Cr | -0.36 Cr | — |
| Net Non Operating Interest Income Expense | -0.10 Cr | -0.16 Cr | -0.77 Cr | -2.86 Cr | — |
| Interest Expense Non Operating | 0.10 Cr | 0.16 Cr | 1.36 Cr | 3.28 Cr | — |
| Operating Income | 359.94 Cr | 201.14 Cr | 194.01 Cr | 227.50 Cr | — |
| Operating Expense | 208.82 Cr | 196.06 Cr | 182.22 Cr | 157.33 Cr | — |
| Other Operating Expenses | 130.04 Cr | 114.78 Cr | 63.05 Cr | 53.82 Cr | — |
| Depreciation And Amortization In Income Statement | 17.79 Cr | 28.09 Cr | 25.07 Cr | 21.76 Cr | — |
| Depreciation Income Statement | 17.79 Cr | 28.09 Cr | 25.05 Cr | 21.76 Cr | — |
| Gross Profit | 568.76 Cr | 397.20 Cr | 376.24 Cr | 384.83 Cr | — |
| Cost Of Revenue | 461.22 Cr | 314.40 Cr | 344.29 Cr | 293.65 Cr | — |
| Total Revenue | 1.03K Cr | 711.60 Cr | 720.53 Cr | 678.48 Cr | — |
| Operating Revenue | 1.03K Cr | 711.60 Cr | 720.53 Cr | 678.48 Cr | — |
| Tax Effect Of Unusual Items | 0.00 | -2.49 Cr | 1.86 Cr | 0.40 Cr | — |
| Tax Rate For Calcs | 0.25 | 0.26 | 0.26 | 0.25 | — |
| Normalized EBITDA | 423.99 Cr | 258.09 Cr | 235.83 Cr | 266.69 Cr | — |
| Total Unusual Items | 0.00 | -9.74 Cr | 7.21 Cr | 1.58 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.00 | -9.74 Cr | 7.21 Cr | 1.58 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 305.20 Cr | 163.75 Cr | 160.03 Cr | 181.59 Cr | — |
| Reconciled Depreciation | 17.79 Cr | 28.09 Cr | 25.07 Cr | 21.76 Cr | — |
| Reconciled Cost Of Revenue | 461.22 Cr | 314.40 Cr | 344.29 Cr | 293.65 Cr | — |
| EBITDA | 423.99 Cr | 248.35 Cr | 243.04 Cr | 268.27 Cr | — |
| Net Income Including Noncontrolling Interests | 305.20 Cr | 163.75 Cr | 160.03 Cr | 181.59 Cr | — |
| Net Income Continuous Operations | 305.20 Cr | 163.75 Cr | 160.03 Cr | 181.59 Cr | — |
| Interest Income | — | 2.82 Cr | 0.59 Cr | 0.44 Cr | 0.62 Cr |
| Other Special Charges | — | 10.66 Cr | -0.10 Cr | -0.03 Cr | 5.20 Cr |
| Total Other Finance Cost | — | 20000.00 | 20000.00 | 0.02 Cr | 0.62 Cr |
| Interest Income Non Operating | — | 2.82 Cr | 0.59 Cr | 0.44 Cr | 0.62 Cr |
| Amortization | — | 0.09 Cr | 0.02 Cr | 0.00 | 60000.00 |
| Selling General And Administration | — | 27.25 Cr | 32.70 Cr | 36.43 Cr | 30.82 Cr |
| Selling And Marketing Expense | — | 19.64 Cr | 27.27 Cr | 32.28 Cr | 24.43 Cr |
| General And Administrative Expense | — | 7.62 Cr | 5.43 Cr | 4.15 Cr | 6.39 Cr |
| Impairment Of Capital Assets | — | — | 0.00 | 0.39 Cr | 0.00 |
| Minority Interests | — | — | 0.00 | 0.00 | 2.63 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Blue Jet Healthcare Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.